Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Lynx1 Capital Management Lp

10% Owner at Cullinan Therapeutics, Inc. (CGEM); 10% Owner at Korro Bio, Inc. (KRRO); 10% Owner at Neuphoria Therapeutics Inc. (NEUP); 10% Owner at TScan Therapeutics, Inc. (TCRX)

Purchase track record

Strong record. Based on 4 purchases with a full 90 days of price history.

89
Avg. 90-day return+23.2%
vs. S&P 500+21.9%
Beat the market75%
Paper profit on buys+$13.3M
Total bought / sold$15.4M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Aug 13SEC KRROKorro Bio, Inc. Buy 5,2221,543,518 held (+0%) $11.40 $60K -10.9%
Aug 13SEC KRROKorro Bio, Inc. Buy 1,4621,544,980 held (+0%) $13.19 $19K -23.0%
Dec 23SEC TCRXTScan Therapeutics, Inc. Buy 80,0697,937,416 held (+1%) $0.90 $72K -73.6%
Dec 23SEC TCRXTScan Therapeutics, Inc. Buy 75,5008,012,916 held (+1%) $0.90 $68K -73.6%
Dec 23SEC TCRXTScan Therapeutics, Inc. Buy 6,2328,019,148 held (+0%) $0.90 $6K -73.6%
Oct 23SEC NEUPNeuphoria Therapeutics Inc. Buy 639,110875,328 held (+271%) $5.14 $3.3M -34.6%
Oct 21SEC CGEMCullinan Therapeutics, Inc. Buy 15,0328,564,116 held (+0%) $7.59 $114K +104.6%
Oct 21SEC CGEMCullinan Therapeutics, Inc. Buy 51,5008,615,616 held (+1%) $7.94 $409K +95.6%
Oct 21SEC CGEMCullinan Therapeutics, Inc. Buy 150,0008,765,616 held (+2%) $8.86 $1.3M +75.3%
Oct 21SEC CGEMCullinan Therapeutics, Inc. Buy 32,2178,797,833 held (+0%) $7.84 $253K +98.1%
Oct 10SEC CGEMCullinan Therapeutics, Inc. Buy 556,3007,645,743 held (+8%) $6.46 $3.6M +140.4%
Oct 10SEC CGEMCullinan Therapeutics, Inc. Buy 626,0438,271,786 held (+8%) $6.70 $4.2M +131.8%
Oct 10SEC CGEMCullinan Therapeutics, Inc. Buy 277,2988,549,084 held (+3%) $7.36 $2.0M +111.0%
  • Buy

    10% Owner Lynx1 Capital Management Lp bought $60K of KRRO at $11.40 — first open-market purchase in our records.

  • Buy

    10% Owner Lynx1 Capital Management Lp bought $72K of TCRX at $0.90 — first open-market purchase in our records.

  • Buy

    10% Owner Lynx1 Capital Management Lp bought $3.3M of NEUP at $5.14 — first open-market purchase in our records; raises the stake by 271%.

  • Buy

    10% Owner Lynx1 Capital Management Lp bought $3.6M of CGEM at $6.46 — first open-market purchase in our records.

  • Buy

    10% Owner Lynx1 Capital Management Lp bought $4.2M of CGEM at $6.70 — largest purchase by this insider in our records.